Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Crystalloid vs Erythrocyte Prime in Isolated Limb Perfusion
NCT03073304Completed
- Sponsor
- Region Västra Götaland
- Start
- Feb 2017
- Primary completion
- Feb 2018
- Countries
- 1
01
Overview
Randomised, open-label trial in melanoma and sarcoma (2 arms), sponsored by Region Västra Götaland. Primary endpoint: Lactate level at 1 hour. Started Feb 2017; status: completed.
02
Conditions
melanomasarcoma
Beyond the preview
Go deeper on NCT03073304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03073304.